Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, indicating a newer site build.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew latest revision v3.5.3 is added to the history, replacing the previous v3.5.2. This reflects a minor metadata update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision v3.5.2 was added and v3.5.0 was removed in the page's history.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.5.0 is active on the page, replacing v3.4.3 as part of a site-wide update to the UI and underlying system.SummaryDifference0.0%

- Check72 days agoChange DetectedA new revision entry v3.4.3 was added to the history and the v3.4.2 entry was removed.SummaryDifference0.0%

- Check80 days agoChange DetectedStudy Status updated to Completed on 2026-02-25 and Recruitment Status added on 2026-02-12. The previous status 'Active, not recruiting' was removed on 2025-10-24.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.